P

Inventor

TAO WEIKANG

CN52 patents
⚠️ This page may combine multiple inventors who share the name “TAO WEIKANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JIANGSU HENGRUI MEDICINE CO

37 patents
US10905743B2Feb 2, 2021

Interleukin 15 protein complex

JIANGSU HENGRUI MEDICINE CO9 citations85
US10633375B2Apr 28, 2020

Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof

JIANGSU HENGRUI MEDICINE CO6 citations84
US11717559B2Aug 8, 2023

Interleukin 15 protein complex and use thereof

JIANGSU HENGRUI MEDICINE CO2 citations72
US11274142B2Mar 15, 2022

Fusion protein containing TGF-β receptor and medicinal uses thereof

JIANGSU HENGRUI MEDICINE CO3 citations72
US10906905B2Feb 2, 2021

Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereof

JIANGSU HENGRUI MEDICINE CO2 citations72
US12202891B2Jan 21, 2025

Antibody capable of binding to thymic stromal lymphopoietin and use thereof

JIANGSU HENGRUI MEDICINE CO2 citations71
US10442793B2Oct 15, 2019

Oxa spiro derivative, preparation method therefor, and applications thereof in medicines

JIANGSU HENGRUI MEDICINE CO2 citations70
US11359021B2Jun 14, 2022

PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof

JIANGSU HENGRUI MEDICINE CO2 citations69
US11117898B2Sep 14, 2021

Pyrazolo-heteroaryl derivative, preparation method and medical use thereof

JIANGSU HENGRUI MEDICINE CO3 citations69
US10449250B2Oct 22, 2019

Anti-sclerostin antibody, antigen binding fragment and medical use thereof

JIANGSU HENGRUI MEDICINE CO2 citations69
US11111249B2Sep 7, 2021

Heteroaryl-pyrazole derivative, and preparation method therefor and medical application thereof

JIANGSU HENGRUI MEDICINE CO3 citations66
US12428478B2Sep 30, 2025

Anti-Claudin 18.2 antibody and application thereof

JIANGSU HENGRUI MEDICINE CO1 citations63
US12258394B2Mar 25, 2025

IL-5 antibody, antigen binding fragment thereof, and medical application therefor

JIANGSU HENGRUI MEDICINE CO1 citations62
US11084808B2Aug 10, 2021

Oxopicolinamide derivative, preparation method therefor and pharmaceutical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations62
US10899837B2Jan 26, 2021

B7-H3 antibody, antigen-binding fragment thereof and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations62
US10889569B2Jan 12, 2021

Condensed ring group azacyclobutyl triazole derivative, preparation method therefor and use thereof in medicine

JIANGSU HENGRUI MEDICINE CO1 citations62
US12187684B2Jan 7, 2025

Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations61
US11512055B2Nov 29, 2022

Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (RORγ) and pharmaceutical uses thereof

JIANGSU HENGRUI MEDICINE CO1 citations61
US11981733B2May 14, 2024

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations60
US11365247B2Jun 21, 2022

IL-5 antibody, antigen binding fragment thereof, and medical application therefor

JIANGSU HENGRUI MEDICINE CO1 citations60
US11345753B2May 31, 2022

TIM-3 antibody, antigen binding fragment thereof, and medicinal uses thereof

JIANGSU HENGRUI MEDICINE CO1 citations60
US11312705B2Apr 26, 2022

Heteroaryl[4,3-C]pyrimidine-5-amine derivative, preparation method therefor, and medical uses thereof

JIANGSU HENGRUI MEDICINE CO1 citations60
US11155617B2Oct 26, 2021

LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations60
US12404323B2Sep 2, 2025

Antibody capable of binding to thymic stromal lymphopoietin and use thereof

JIANGSU HENGRUI MEDICINE CO0 citations59
US12325741B2Jun 10, 2025

Anti-Aβ antibodies and antigen-binding fragments thereof

JIANGSU HENGRUI MEDICINE CO0 citations59
US12258405B2Mar 25, 2025

CD3 antibody and pharmaceutical use thereof

JIANGSU HENGRUI MEDICINE CO1 citations59
US11512129B2Nov 29, 2022

TIGIT antibody, antigen-binding fragment thereof, and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations59
US11535633B2Dec 27, 2022

Fused tricyclic heterocycle compounds and therapeutic uses thereof

JIANGSU HENGRUI MEDICINE CO2 citations58
US11247998B2Feb 15, 2022

Piperazine heteroaryl derivative, preparation method therefor and use of same in medicine

JIANGSU HENGRUI MEDICINE CO0 citations52
US12325696B2Jun 10, 2025

Indazole derivative, preparation method therefor, and pharmaceutical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations51
US12162879B2Dec 10, 2024

Pyridopyrimidine derivative, preparation method therefor and medical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations50
US11332492B2May 17, 2022

CD73 inhibitors and therapeutic uses thereof

JIANGSU HENGRUI MEDICINE CO0 citations50
US10899741B2Jan 26, 2021

3,4-bipyridyl pyrazole derivative, and preparation method therefor and medical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations50
US12428428B2Sep 30, 2025

Tricyclic tetrahydroisoquinoline derivative, preparation method therefor and application thereof in medicine

JIANGSU HENGRUI MEDICINE CO0 citations49
US10793643B2Oct 6, 2020

PCSK9 antibody, antigen-binding fragment thereof, and medical application thereof

JIANGSU HENGRUI MEDICINE CO0 citations49
US12428482B2Sep 30, 2025

Anti-PD-1 antibody, antigen-binding fragment thereof and pharmaceutical use thereof

JIANGSU HENGRUI MEDICINE CO0 citations47
US11014904B2May 25, 2021

1,2,4-triazine-3-amine derivative, preparation method therefor, and use thereof in medicine

JIANGSU HENGRUI MEDICINE CO0 citations46

SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD

5 patents

JIANGSU HENGRUI PHARMACEUTICALS CO LTD

4 patents

Shanghai hengrui pharmaceutical co ltd

2 patents

HANSOH SHANGHAI HEALTHTECH CO LTD

1 patent

JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD

1 patent

Showing the top 50 of 52 patents by PatentIndex Score.